# Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

> **NCT00926367** · PHASE4 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 52 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Clindamycin and benzoyl peroxide
- **DRUG:** benzoyl peroxide 2.5% and adapalene 0.1% gel

## Key facts

- **NCT ID:** NCT00926367
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-07
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2015-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926367, "Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00926367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*